MOLECULAR DETERMINANTS OF AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE - CONFORMATIONAL STUDIES OF SYNTHETIC BETA-PROTEIN FRAGMENTS

被引:311
作者
HALVERSON, K
FRASER, PE
KIRSCHNER, DA
LANSBURY, PT
机构
[1] MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA
[2] CHILDRENS HOSP MED CTR, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA
关键词
D O I
10.1021/bi00463a003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid 0-protein (1–42) is a major constituent of the abnormal extracellular amyloid plaque that characterizes the brains of victims of Alzheimer’s disease. Two peptides, with sequences derived from the previously unexplored C-terminal region of the 0-protein, 026–33 (H2N-SNKGAIIG-CO2H) and β34-42 (H2N-LMVGGVVIA-CO2H), were synthesized and purified, and their solubility and conformational properties were analyzed. Peptide β26-33 was found to be freely soluble in water; however, peptide β34-42 was virtually insoluble in aqueous media, including 6 M guanidinium thiocyanate. The peptides formed assemblies having distinct fibrillar morphologies and different dimensions as observed by electron microscopy of negatively stained samples. X-ray diffraction revealed that the peptide conformation in the fibrils was cross-β. A correlation between solubility and 0-structure formation was inferred from FTIR studies: β26-33, when dissolved in water, existed as a random coil, whereas the water-insoluble peptide β34-42 possessed antiparallel β-sheet structure in the solid state. Solubilization of β34-42 in organic media resulted in the disappearance of β-structure. These data suggest that the sequence 34–42, by virtue of its ability to form unusually stable β-structure, is a major contributor to the insolubility of the β-protein and may nucleate the formation of the fibrils that constitute amyloid plaque. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2639 / 2644
页数:6
相关论文
共 49 条
[1]   CONFORMATIONAL PROPERTIES OF L-LEUCINE, L-ISOLEUCINE, AND L-NORLEUCINE SIDE-CHAINS IN L-LYSINE COPOLYMERS [J].
ARFMANN, HA ;
LABITZKE, R ;
WAGNER, KG .
BIOPOLYMERS, 1977, 16 (08) :1815-1826
[2]   MASS-SPECTROMETRIC METHODS FOR PROTEIN SEQUENCING [J].
BIEMANN, K .
ANALYTICAL CHEMISTRY, 1986, 58 (13) :1288-&
[3]  
CANDY JM, 1986, LANCET, V1, P354
[4]   ALZHEIMERS-DISEASE - ENTER A PROTEASE INHIBITOR [J].
CARRELL, RW .
NATURE, 1988, 331 (6156) :478-479
[5]  
CASTANO EM, 1988, LAB INVEST, V58, P122
[6]   INVITRO FORMATION OF AMYLOID FIBRILS FROM 2 SYNTHETIC PEPTIDES OF DIFFERENT LENGTHS HOMOLOGOUS TO ALZHEIMERS-DISEASE BETA-PROTEIN [J].
CASTANO, EM ;
GHISO, J ;
PRELLI, F ;
GOREVIC, PD ;
MIGHELI, A ;
FRANGIONE, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) :782-789
[7]  
Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
[8]   SOLID-PHASE SYNTHESIS OF PROTECTED PEPTIDES ON A POLYMER-BOUND OXIME - PREPARATION OF SEGMENTS COMPRISING THE SEQUENCE OF A CYTO-TOXIC 26-PEPTIDE ANALOG [J].
DEGRADO, WF ;
KAISER, ET .
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (17) :3258-3261
[9]   POLYMER-BOUND OXIME ESTERS AS SUPPORTS FOR SOLID-PHASE PEPTIDE-SYNTHESIS - PREPARATION OF PROTECTED PEPTIDE-FRAGMENTS [J].
DEGRADO, WF ;
KAISER, ET .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (07) :1295-1300
[10]   SYNTHESIS AND STRUCTURAL INVESTIGATION OF POLY(L-ALANYL-L-ALANYL-GLYCINE) [J].
DOYLE, BB ;
TRAUB, W ;
LORENZI, GP ;
BROWN, FR ;
BLOUT, ER .
JOURNAL OF MOLECULAR BIOLOGY, 1970, 51 (01) :47-&